vTv Therapeutics (VTVT) Return on Equity (2016 - 2025)
Historic Return on Equity for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to 0.77%.
- vTv Therapeutics' Return on Equity rose 4100.0% to 0.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77%, marking a year-over-year increase of 4100.0%. This contributed to the annual value of 4.38% for FY2024, which is 29100.0% up from last year.
- As of Q3 2025, vTv Therapeutics' Return on Equity stood at 0.77%, which was up 4100.0% from 4.1% recorded in Q2 2025.
- In the past 5 years, vTv Therapeutics' Return on Equity registered a high of 2.94% during Q2 2022, and its lowest value of 40.11% during Q1 2024.
- For the 5-year period, vTv Therapeutics' Return on Equity averaged around 1.84%, with its median value being 0.19% (2021).
- In the last 5 years, vTv Therapeutics' Return on Equity plummeted by -415400bps in 2024 and then skyrocketed by 381300bps in 2025.
- Over the past 5 years, vTv Therapeutics' Return on Equity (Quarter) stood at 1.13% in 2021, then surged by 62bps to 1.84% in 2022, then tumbled by -43bps to 1.04% in 2023, then crashed by -235bps to 1.41% in 2024, then skyrocketed by 45bps to 0.77% in 2025.
- Its last three reported values are 0.77% in Q3 2025, 4.1% for Q2 2025, and 1.97% during Q1 2025.